Top Markets
#1 Tutorial Tutorial +47.24%
#2 Official Trump Official Trump +27.13%
#3 Unit Pump Unit Pump +24.13%
#4 Pump.fun Pump.fun +24.13%
#5 Siacoin Siacoin +23.94%
#6 EXOD EXOD +18.93%
#7 MowCat MowCat +18.41%
#8 Stacks Stacks +17.70%
#9 Melania Meme Melania Meme +17.42%
#10 LayerZero LayerZero +16.67%
Coin of the day
Tutorial Tutorial
Settings
Language
ENGLISH
Currency
USD
Theme
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rank in Stocks #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Share Price
$0.49606484
Last synced: 2026-08-21
Market Cap
$88.47M
Change (1 day)
-1.58%
Change (1 year)
-22.51%
Country
TW
Trade Intech Biopharm Corporation (6461)

Category

Healthcare
Earnings for Intech Biopharm Corporation (6461)
Earnings in 2026 TTM: 0
According to Intech Biopharm Corporation latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Intech Biopharm Corporation from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH